In 2023, Humanwell Pharmaceutical Excipients developed rapidly, and has achieved a series of significant achievements. Then let's look at what events Humanwell Pharmaceutical Excipients has!
1. Signed With IBM to Contribute to International Development of Humanwell
Humanwell successfully signed a contract with IBM. Humanwell' digital construction and international development has taken solid steps.
2. Breakthroughs On EU Registration Procedures and Processing of Veterinary Health Certificate
The EU registration procedures of Humanwell have been reviewed and recommended to the EU official by the Customs Administration. At the same time, the processing of veterinary health certificate has made breakthroughs, contributing to the sales growth of Humanwell products in major markets such as the European Union and the United States.
3. cGMP Quality System Improvement and FDA DMF Filing
Humanwell officially launched the cGMP quality system improvement and FDA DMF filing. After the filing and association is completed, it will become the first one in China and the fourth one in the world who produces Empty Capsules and enters into the United States pharmaceutical market. After that, competitive advantage of Humanwell in overseas markets will be significantly improved.
4. Breakthroughs on Patents
In 2023, the authorized new invention patents exceeded 5 for the first time, and the total number of effective patents was 29.
5. Humanwell Liquid Filled Capsule Samples Exhibited in the Las Vegas Exhibition
The samples self-developed by Humanwell and produced by the first inner sealing equipment of Liquid-Filled Capsule in China were exhibited in the Las Vegas Exhibition of US for the first time. Humanwell became the second one in the world who produced Liquid-Filled Capsules. In the exhibition, Humanwell won high appreciation and recognition from European and American customers, which laid a good market foundation for the export of new liquid filled capsule products.
6. Branches Established Overseas
In 2023, the company set up sales companies (offices) overseas for the first time, and successfully set up four sales companies (offices), including New Jersey company, Delaware Company, Hong Kong company and Thailand office, effectively supporting the company's international development.
About Humanwell Pharmaceutical Excipients
Hubei Humanwell Pharmaceutical Excipients Co., Ltd.is a high-tech branch of Humanwell Healthcare Group, specializing in the production of capsules, and with over 20 years of capsules production experience.
With planned total annual production capacity of 40 billions of empty capsules.
Currently has 16 imported automatic capsule production lines, with an annual production capacity of 15 billions of capsules.
